Table of Contents
Evaluating progress with next-generation techniques across multiple pathologies.
Experts address the challenges of TBAD and share their perspectives on the first FDA-approved endovascular system designed specifically for managing type B aortic dissection.
Sponsored by Cook Medical
In This Issue
Guest Chief Medical Editors' Page
Ask the Experts: Does Early TEVAR Prevent Aneurysmal Degeneration?
Selection criteria, results of studies comparing medical therapy with TEVAR, and what future studies should seek to evaluate.
With William J. Quinones-Baldrich, MD; Eric L.G. Verhoeven, MD, PhD; Edward Y. Woo, MD; Chandler A. Long, MD; Cynthia K. Shortell, MD; Wei Zhou, MD, FACS; Joshua Leon Black, BS; Wei Guo, MD, PhD; and Cherrie Abraham, MD
Ask the Experts: Acute TBAD: What Is Your Strategy Regarding Extent of Coverage and Use of Covered Versus Bare Stents?
Expert insight on treatment options for TBAD via TEVAR.
With Ali Azizzadeh, MD, FACS; Ian M. Loftus, MD, FRCS; Audra A. Duncan, MD, FACS, FRCSC; Joseph Lombardi, MD; and Germano Melissano, MD
Surgical Approaches to Repair of Aberrant Subclavian Artery and Kommerell Diverticulum
Highlighting the evolution of repair of aberrant subclavian artery and symptomatic Kommerell diverticulum with aneurysmal degeneration, from open repair to a hybrid approach to the future of total endovascular repair.
By Javairiah Fatima, MD, FACS, FSVS
European Featured Technology
Sponsored by JOTEC GmbH, a fully owned subsidiary of CryoLife, Inc.
Medical Affairs Corner
November 2019 Supplement